NS
Article DetailSEC EDGAR Filings
首页文档检索台
SEC EDGAR Filings

4 - Doyle John Brendan

Filed: 2026-04-20 AccNo: 0001104659-26-045511 Size: 4 KB
查看原文来源主页查看事件簇按来源查看
发布时间04/20 20:18 UTC
首次发现04/20 20:23 UTC
热度106.2
重要度74
情绪0.00

站内整理正文

优先显示结构化正文；如果正文还未抽出，则回退到摘要。
sec_edgar_index_v1 · 547 字符

Form 4 - Statement of changes in beneficial ownership of securities: SEC Accession No. 0001104659-26-045511

Filing Date: 2026-04-20

Accepted: 2026-04-20 16:18:30

Documents: 1

Period of Report: 2026-04-16

COGNITION THERAPEUTICS INC ( Issuer ) CIK : 0001455365 (see all company filings) EIN. : 000000000 | State of Incorp.: DE | Fiscal Year End: 1231 SIC : 2836 Biological Products, (No Diagnostic Substances) (CF Office: 03 Life Sciences)

1 | OWNERSHIP DOCUMENT | tm2612247-3_4seq1.html | 4

1 | OWNERSHIP DOCUMENT | tm2612247-3_4seq1.xml | 4